Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Koninklijke Philips NV (PHG) Price & Performance

Novartis AGTrade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Koninklijke Philips NV — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Koninklijke Philips NV trades at $26.77 (market cap $26.19B). The key difference: Novartis AG is far larger — about 11.1× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (3.79%). Which is the better fit depends on your goals.

NVSPHG
Market Cap
$290.25B$26.19B
Sector
HealthHealth
52-Week High
$168.62$32.91
52-Week Low
$113.50$24.54
Enterprise Value
$330.27B$32.46B
Dividend Yield
3.17%3.79%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG